Newcastle upon Tyne, United Kingdom

Chris Morris

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ge Healthcare Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chris Morris. Retrieved from https://idiyas.com/inventor/chris-morris-mf42mvf3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chris Morris - Innovator in Depression Biomarkers

Introduction

Chris Morris is a notable inventor based in Newcastle upon Tyne, GB. He has made significant contributions to the field of mental health through his innovative research and inventions. His work focuses on understanding and addressing late-onset depression, a condition that affects many individuals.

Latest Patents

Chris Morris holds a patent for "GABA biomarkers for depression." This invention demonstrates the differential expression of nucleic acids in the brains of subjects suffering from late-onset depression. The methods provided by this invention are useful in determining the presence of late-onset depression. Additionally, it includes a screening method for identifying compounds that can be used for the treatment, prevention, or diagnosis of this condition. He has 1 patent to his name.

Career Highlights

Chris is currently employed at GE Healthcare Limited, where he continues to work on innovative solutions in healthcare. His research has the potential to impact the lives of many individuals suffering from mental health issues.

Collaborations

Throughout his career, Chris has collaborated with talented individuals such as Peter Hanson and Duncan Hiscock. These collaborations have enriched his research and contributed to the advancement of his inventions.

Conclusion

Chris Morris is a dedicated inventor whose work in the field of depression biomarkers is paving the way for new methods of diagnosis and treatment. His contributions are vital in the ongoing fight against mental health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…